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Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) cause a chronic inflammatory response in the lung of patients
with Cystic Fibrosis (CF). We have showed that TNF-α signaling through the Src family tyrosine kinases (SFKs) was defective as determined by
an inability of TNF-α to regulate gap junctional communication (GJIC) in CF cells. Here, we sought to elucidate the mechanisms linking TNF-α
signaling to the functions of CFTR at the molecular level. In a MDCKI epithelial cell model expressing wild-type (WtCFTR) or mutant CFTR
lacking its PDZ-interacting motif (CFTR-ΔTRL), TNF-α increased the amount of WtCFTR but not CFTR-ΔTRL in detergent-resistant membrane
microdomains (DRMs). This recruitment was modulated by SFK activity and associated with DRM localization of TNFR1 and c-Src. Activation
of TNFR1 signaling also decreased GJIC and markedly stimulated IL-8 production in WtCFTR cells. In contrast, the absence of CFTR in DRMs
was associated with abnormal TNFR1 signaling as revealed by no recruitment of TNFR1 and c-Src to lipid rafts in CFTR-ΔTRL cells and loss of
regulation of GJIC and IL-8 secretion. These results suggest that localization of CFTR in lipid rafts in association with c-Src and TNFR1 provides
a responsive signaling complex to regulate GJIC and cytokine signaling.
© 2008 Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; CFTR; Lipid rafts; Tumor necrosis factor; Src tyrosine kinase; Inflammation; IL-8; Gap junctions1. Introduction
Cystic fibrosis (CF) is an autosomal recessive disease re-
sulting from mutations of the CF transmembrane conductance
regulator (CFTR) gene. CFTR, a member of the adenine nu-
cleotide-binding cassette family, is an ATP- and cAMP-de-
pendent protein kinase A (PKA)-regulated chloride channel
present at the apical surface of epithelial cells. The ΔF508
mutation, which accounts for 70% of the cases in Caucasians,
is retained at the endoplasmic reticulum and consequently is
unable to function at the plasma membrane [1,2]. In CF lungs,
the release of a variety of cytokines and chemokines, such as⁎ Corresponding author. Tel.: +41 22 3734611; fax: +41 22 3724088.
E-mail address: Marc.Chanson@hcuge.ch (M. Chanson).
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doi:10.1016/j.bbamcr.2008.01.007tumor necrosis factor-α (TNF-α) and interleukin-8 (IL-8), along
with an excessive neutrophil influx and recurrent infection by
Pseudomonas aeruginosa (Pa), lead to a progressively destruc-
tive inflammatory reaction and loss of pulmonary function [3].
CFTR is also a regulator of other membrane transport proteins,
including ENaC sodium channels, outwardly rectifying chloride
channels, bicarbonate exchangers/co-transporters, ROMK po-
tassium channels, aquaporin3 water channels as well as gap
junction channels [1,4,5]. Defective regulation of channel acti-
vity in CF cells is thus thought to contribute to the phenotypes
of the disease.
Gap junctions contain hydrophilic membrane channels that
allow direct communication between neighboring cells (GJIC)
through the diffusion of ions, metabolites, and small cell sig-
naling molecules. They are composed of a hexameric array of
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is crucial to tissue homeostasis, the alteration of which con-
tributing to disease initiation and/or progression. In addition to
their coupling function, recent studies suggest that connexin
proteins may also mediate signaling. The integration of these
cell functions is likely to be important in the role of gap junc-
tions in development and disease [6]. We have reported that
CFTR dysfunction is associated with altered TNF-α signaling
in CF airway epithelial cells, resulting in the persistence of gap
junction connectivity. While TNF-α induced the disruption of
GJIC through a c-Src family kinase (SFK)-dependent pathway
within minutes, the cytokine failed to modulate GJIC in CF cells
[7,8]. Although these results suggest that c-Src is a central
element in the signaling pathway connecting CFTR with Cx43
in airway epithelial cells, the mechanism by which CFTR in-
tersects with SFKs during TNF-α stimulation is unknown.
Emerging evidence indicates that lipid microenviroments on
the cell surface, known as lipid rafts, are critically involved in
distal signaling events [9]. Lipid rafts are specialized membrane
microdomains enriched in glycosphingolipids and cholesterol
that resist detergent solubilization and can be found in low-
density fractions on density gradients. These low-density de-
tergent-resistant membranes (DRMs) provide a spatial compart-
mentalization of receptors and kinases that facilitates their
interactions and the activation of downstream responses [10].
This is particularly relevant to the TNF-α signaling pathway,
which triggers a variety of biological responses depending on
the localization of the TNF-α receptor 1 (TNFR1) in lipid rafts
[11,12]. Interestingly, two recent studies reported that CFTR
associates with lipid rafts in epithelial cells [13,14]. Although
these observations are consistent with the idea that localiza-
tion of CFTR in lipid raft may trigger distinct intracellular cell
responses, the role of CFTR inDRMs has only been evaluated so
far by extraction of cell surface cholesterol [14], an approach
that does not specifically targets CFTR in lipid rafts.
In an attempt to gain more insights into the role of CFTR in
lipid rafts, we studied the dynamic partition of CFTR in DRMs
in response to TNF-α and evaluated Cx43-mediated GJIC as
well as IL-8 production in MDCKI cells expressing wild-type
(WtCFTR) or a mutant CFTR lacking its last three amino
acids (CFTR-ΔTRL) [15,16]. We report here that expression of
CFTR, in association with c-Src and TNFR1 presented within
the context of lipid rafts, provides a responsive signaling complex
at the surface of MDCKI cells to regulate GJIC and cytokine
signaling.
2. Materials and methods
2.1. Cell lines
Madin–Darby canine kidney cells type I (MDCKI) transfected with a
plasmid expressing either a green fluorescent protein (GFP)-tagged to wild-type
CFTR (WtCFTR), GFP-tagged to CFTR lacking its C-terminal PDZ (PSD-95,
Dlg, and ZO-1)-binding domain (CFTR-ΔTRL) or GFP-tagged to the ΔF508
mutant (ΔF508CFTR) were described previously [15,16]. GFP, which is fu-
sed to the N-terminus of CFTR, has been shown to have no effect on CFTR
localization, processing or function [15,16]. GFP-CFTR-expressing MDCKI
and parental cells were treated overnight with 5 mM sodium butyrate (Sigma
Chemical Co., St. Louis, MO) before experiments to increase CFTR expression.Most experiments were performed on sub-confluent cultures to prevent the
down-regulation of Cx43 expression previously observed in confluent mo-
nolayers of MDCK cells [17]. In some experiments, MDCKI cells were cultured
at high density on Transwell inserts to enhance cell polarization. Additional
experiments were also performed on BHK cells stably expressing wild-type
(untagged) CFTR and MDCKII cells expressing a mutant CFTR with GFP
fused at its C-terminus [18]. Calu-3 cells, a human glandular cell line that
endogenously expresses normal CFTR, were from the American Type Culture
Collection (ATCC, Manassas, VA). All cells were grown in Dulbecco's
modified Eagle's medium supplemented with 10% fetal calf serum (SeraTech,
Griesbach, Switzerland), 30 units/ml penicillin, and 30 µg/ml streptomycin
(Invitrogen AG, Basel, Switzerland).
2.2. Cell treatment
Prior to an experiment, the culture medium was removed and cells were
rinsed 2×15 min with an external solution (XP) containing (in mM): 136 NaCl,
4 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES and 2.5 glucose (pH 7.4). Cells were
then incubated at 37 °C in XP supplemented with 100 U/ml TNF-α or
isoproterenol for 5–30 min, 25 mM methyl-β-cyclodextrin (CD), 50 µM PP1,
0.4 mM sodium orthovanadate (VO4) and/or 10–40 µM of the CFTR inhibitor
I-172 for 45 min. All agents were from Sigma except TNF-α (Bachem AG,
Bubendorf, Germany).
2.3. Lipid raft preparation
Cells were washed twice in Dulbecco's phosphate buffer saline (PBS)
containing CaCl2 and MgCl2 at 4 °C. Cells were then scraped off in the cell
culture dish in cold PBS and spun for 2 min at 500×g. The supernatant was
discarded and the cells lysed for 30 min in 1% Triton X-100 prepared in 25 mM
Tris–HCl (pH 7.4), 150 mM NaCl and 5 mM EDTA (TNE) in the presence of
Complete Mini Protease Inhibitor Cocktail (Roche Diagnostics, Rotkreuz,
Switzerland). Detergent resistant membranes (DRMs) were prepared by sucrose
density gradient isolation using the Optiprep method (Axon Lab AG, Baden,
Switzerland). Briefly, cells were lysed in 200 µl of TNE, well mixed with 400 µl
Optiprep 60% and transferred to an ultracentrifuge tube. Before centrifugation,
2× 600 µl Optiprep 30% followed by 600 µl TNE was added to the tube.
Samples were spun 2 h at 148,000 ×g using a S55S rotor (Sorvall Discovery
M150 GX). At the end of the centrifugation period, 8 fractions of 300 µl each
were removed starting from the top of the Optiprep gradient. DRMs reach their
isopycnic point at the interphase 0/30% OptiPrep (fractions 2 and 3). Fractions
were stored at −20 °C before further processing. For these experiments,
WtCFTR and CFTR-ΔTRL cells were grown to 70–80% confluence before cell
lysis. No difference was observed in terms of protein content between WtCFTR
(1.5±1 µg/µl, n=25 extractions) and CFTR-DTRL (1.3±0.2 µg/µl, n=10
extractions) cells. No correlation was found between protein load and CFTR
recovered in lipid rafts in WtCFTR cells within the range 0.3–4.4 µg/µl of
protein. Within this very same range of protein concentration, CFTR-ΔTRL was
not detected in DRMs.
2.4. Western blotting
For each fraction, a sample was mixed with 4× NuPAGE lithium dodecyl
sulfate (LDS) Sample buffer (Invitrogen) containing 100 mM 1,4-Dithio-DK-
threitol (Fluka, Buchs, Switzerland) to reach 1X final concentration of the buffer
and incubated for 30 min at 37 °C. From each of the 8 fractions, 15 µl of protein
sample were electrophoresed on a 7.5% SDS-PAGE and electrotransferred onto
Immobilon-P polyvinylidene difluoride membranes (Millipore AG, Volketswill,
Switzerland). Membranes were then blocked for 1 h in a 5% defatted milk
saturation buffer containing 20 mM Tris–HCl (pH 7.6), 150 mM NaCl, 0.1%
Tween20 and 0.2% sodium azide. Blots were next incubated overnight at 4 °C
with antibodies against flottilin-1 or caveolin-1 (kindly provided by Dr. G. Van
Der Goot, Medical Faculty, Geneva, Switzerland), GFP (Molecular Probes,
Eugene, OR),TNFR1 (Stressgen Bioreagents, Victoria, BC), v-Src (Calbiochem,
EMD Biosciences Inc., San Diego, CA), EBP50, Fyn, c-Yes or Cx43 (Trans-
duction Laboratories, Lexington, KY). This step was followed by 1-h incubation
with goat anti-mouse or anti-rabbit IgG secondary antibodies conjugated to
peroxidase (The Jackson Laboratories, West Grove, PA). Immunoreactivity was
Fig. 1. GJIC was investigated by dye coupling. The number of Lucifer Yellow
(LY) labeled cells was measured in parental and MDCKI cells expressing
WtCFTR or CFTR-ΔTRL and exposed to TNF-α. A) TNF-α markedly
decreasedGJIC inWtCFTR-expressing cells but not in CFTR-ΔTRL-expressing
cells. Asterisk indicates the injected cell from which Lucifer Yellow diffused to
neighboring cells. Bar represents 20 µm. B)Quantitative analysis of dye coupling
in CFTR-expressing MDCKI cells. Mean±SEM of the number of cells labeled
with Lucifer Yellow are indicated for parental (n=11), WtCFTR (n=18) and
CFTR-ΔTRL (n=13). Asterisk indicates pb0.001.
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IL). The GeneTools software (SynGene, Cambridge, UK) was used to determine
relative band intensities. The M24.1 (directed against the C-terminal) and the
M3A7 (directed against the second nucleotide-binding domain NBD2) antibodies
were used to detect WtCFTR whereas only the M3A7 detected CFTR-ΔTRL. To
ensure for equivalent expression of CFTR in these experiments, we took advantage
that GFP is attached to the N-terminus of both WtCFTR and CFTR-ΔTRL by
performing Western blots using antibodies against the fluorescent tag. Although
there was some variability between experiments, the expression level of GFP-
CFTR and GFP-CFTR-ΔTRL was within the same range (data not shown).
2.5. Biotinylation assay
For biotinylation studies, cells were incubated with 0.5 mg/ml of NHS-LC-
biotin (Pierce Biotechnology) prepared in PBS for 30 min on ice. Cells were then
washed in PBS and scraped to obtain a cell pellet. Cell pellet was then incubated
in the lysis buffer and subjected to Optiprep gradients, as described above. In
most of the experiments, fractions 1, 2 and 3 (DRMs) and 5, 6, 7, and 8 (non-raft
fractions) were pooled. Monomeric avidin-coated beads were added to each
pooled fractions (previously diluted to 50% in PBS), and incubated for 30 min at
4 °C under agitation. Samples were then thoroughly washed in lysis buffer with
protease inhibitor cocktail. The final bead pellet was resuspended in Laemmli
buffer, subjected to SDS-page, and detected by Western blot as described above.
2.6. Dye coupling
Intercellular coupling via gap junctions was evaluated by intracellular
microinjection of Lucifer Yellow, as described in detail previously [17]. Lucifer
Yellow (LY) was prepared in 150 mM LiCl and 10 mM HEPES (pH 7.2).
Tracers were injected into MDCKI cells for 3 min using a thin-tip glass
microelectrode. At the end of the microinjection, the electrode was removed and
the number of LY labeled cells was immediately counted [8]. Experiments were
performed on an inverted TMD-300 microscope (Nikon AG, Küsnacht,
Switzerland) equipped for fluorescence with appropriate filters. Fluorescent
cells were viewed with a 40× phase 3 DM objective with a numerical aperture of
0.7 (Nikon). Images were captured with a Visicam digital camera (Visitron
systems, GmbH, Puchleim, Germany) connected to a personal computer running
Metafluor 4.01 software (Universal Imaging Corp., Downington, PA).
2.7. NF-κB localization
The localization of the nuclear factor (NF)-κB was investigated by im-
munofluorescence. To this end, cells grown on glass coverslips were exposed
for 5–15 min to XP supplemented or not with TNF-α and then fixed in 4%
paraformaldehyde for 15 min followed with cold methanol (−20 °C) for 10 min.
The coverslips were rinsed and with 0.2% Triton X-100 for 1 h, 2% bovine
serum albumin for another 60 min. Cells were the rinsed and incubated for 1 h
with a polyclonal antibody raised against the p65 subunit of NF-κB (Santa
Cruz Biotech. Inc., Santa Cruz, CA). After washing in PBS, the coverslips
were incubated with a secondary Alexa Fluor® 568 goat anti-rabbit antibody
(Molecular Probes Inc., Eugene, OR) for 1 h, and then examined using fluo-
rescent microscopy. Images were acquired as described above. No staining was
observed in the absence of primary antibody.
2.8. IL-8 secretion
IL-8 secretion was evaluated by dot blots. Cells were grown in 6-well culture
plates. The culture mediumwas removed and cells were rinsed twice for 15 min in
XP. Cells were then incubated with or without (control) 100 U/ml TNF-α for
15 min. At the end of the treatment, the cell culture medium was removed and
replaced with 500 µl of fresh XP supplemented with 0.4%BSA for 2 h. At the end
of the 2-h period the supernatant was collected and frozen at −20 °C before further
processing. Plates were washed twice in PBS and exposed with 3 cycles of freeze-
thaw in 500 µl distilled water for cell lysis. Protein content was then determined by
the Bradford method (Bio-Rad protein assay, Bio-Rad Laboratories AG, Reinach,
Switzerland). To detect the amount of secreted IL-8, 100 µl of the collected
supernatant was spotted on Immobilon-P polyvinylidene difluoride membranes
using the Bio-Rad Bio-Dot™ Apparatus. Increasing concentrations (0.1–1 ng/100 µl) of recombinant canine IL-8 (R and D) were also spotted on the membrane
to generate a standard curve. Membranes were blocked in PBS supplemented
with 3% bovine serum albumin (PBS-BSA) for 1 h. Blots were next incubated
overnight at 4 °C with a polyclonal antibody raised in goat against canine IL-8
(R and D). This step was followed by 1-h incubation with a biotin-SP-conjugated
donkey anti-goat IgG secondary antibody and followed by additional 1-h in-
cubation with extravididin conjugated to peroxydase (The Jackson Laboratories).
Immunoreactivity was detected through the Super Signal West Pico kit (Pierce
Biotechnology). The GeneTools software was used to determine relative spot
intensities. IL-8 was expressed as pg/µg of protein.
2.9. Statistical analysis
Experiments were compared using Student's t test. Values are expressed as
mean±SEM. Pb0.05 was considered to be significant.
3. Results
3.1. GJIC in WtCFTR and CFTR-ΔTRL MDCKI cells
We have previously shown that TNF-α reduced GJIC in
normal airway cells expressing Cx43. This mechanism, how-
ever, was defective in CF airway cells expressing the ΔF508
mutant of CFTR [7,8]. To evaluate GJIC in MDCKI cells,
which endogenously express Cx43 [17], we performed dye
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cells and compared the results with those obtained in parental
MDCKI cells. Under basal conditions, Lucifer Yellow rapid-
ly spread from the injected cells to several neighbors in all
three cell types (Fig. 1). TNF-α, however, markedly reduced
(pb0.001) the extent of the dye diffusion in cells expressing
WtCFTR (Fig. 1A and B). In contrast, TNF-α did not affect dye
coupling in parental or CFTR-ΔTRL cells (Fig. 1). Similarly,
GJIC was unaffected by TNF-α in a clone of MDCKI cells
expressing ΔF508CFTR (4.1±0.2 cells as compared to 3.7±0.5
cells under control conditions, n=11). These results confirm
in MDCKI cells our previous findings that WtCFTR confers
sensitivity of Cx43 gap junction channels to TNF-α. In addition,
these results demonstrate the importance of expression of an
intact CFTR protein in mediating TNF-α-dependent regulation
of GJIC.
3.2. DRM-associated proteins in MDCKI cells
Proteins fromMDCKIwere extracted in cold Triton-X100 and
fractioned by density gradient ultracentrifugation. The quality of
the DRM preparation was first examined by Western blots for
specific markers of lipid rafts. As shown in Fig. 2A, caveolin-1
and flotillin-1 were detected in fractions 2 and 3, which cor-
respond to the DRMs. EBP50 (ezrin, radixin and merlin (ERM)-
binding phosphoprotein 50; also referred to as NHERF1), the
adapter molecule that bridges CFTR to the N-terminal domain of
ezrin [16], was detected in all fractions (Fig. 2A). To determine
whether CFTR localized to DRMs, fractions were prepared
from WtCFTR-expressing cells and then immunobloted for
CFTR using an antibody against the NBD2 domain (M3A7)
or the C-terminus domain (M24.1) of the protein, respectively
(Fig. 2B). Although a small amount of GFP-CFTR was found
in lipid rafts, the large majority of the protein was excluded
from DRMs. In all experiments, the identification of CFTR
was confirmed by immunoblots using an antibody against GFP
(data not shown). Quantitative analysis on 10 distinct DRM
preparations revealed that the amount of CFTR detected in lipidFig. 2. Detergent resistant membranes (DRMs) were prepared by ultracentrifugation o
were collected and subjected to Western bloting. Fractions 2 and 3 contain the DRMs
the transition between Triton-insoluble and soluble materials. A)Western blots showin
fromMDCKI cells. The EBP50, a transmembrane adaptor, is found in raft and non-raf
detected in DRMs by the M3A7 and the M24.1 antibodies. Inhibition of raft formatio
(+CD) reduced the basal amount of CFTR in DRMs. Blots are representative of at lerafts averaged 6–7% of the total CFTR protein (Fig. 5B). The
amount of CFTR in DRMs did not increase further in WtCFTR
cells cultured on permeable support (5.1±0.3 % of total CFTR).
However, this proportion decreased markedly in the presence of
methyl-β-cyclodextrin (CD), a membrane cholesterol scavenger
that reduces DRMs (Figs. 2B and 5B). None of the antibodies
used (M24.1, M3A7) detected endogenous CFTR in parental
MDCKI cells (not shown).
3.3. Effect of TNF-α on CFTR and Cx43 in DRMs from
WtCFTR and CFTR-ΔTRL MDCKI cells
We next evaluated the dynamic partition of CFTR and Cx43
in DRMs from WtCFTR and ΔTRL-CFTR cells. Treatment
of WtCFTR cells with TNF-α markedly increased the amount
of CFTR in DRMs (Fig. 3A). We observed a significant
translocation as early as 2 min after TNF-α addition, which
peaked at 5 min and progressively declined to control levels
after 20–30 min (not shown). Quantitative analysis of the
immunoblots revealed that the amount of CFTR detected in
DRMs increased (pb0.01) from 6.6±1.8 % of total CFTR
(n=10) to 21.2±4.2 % (n=7) after 5 min of TNF-α (Fig. 5B).
The translocation of CFTR to DRMs, however, was not
observed in MDCKI cells expressing CFTR-ΔTRL. Although
the mutant CFTR was expressed in these cells, CFTR-ΔTRL
was weakly detected in DRMs in the absence or presence of
TNF-α (Figs. 3B and 5B). We performed additional control
experiments on cells expressing CFTR alone (not fused to GFP)
or CFTR with GFP fused to the C-terminus of the protein,
a situation that abolishes PDZ-dependent interactions [18].
Although the amount of CFTR detected in DRMs was very
variable in these two cell lines, we observed that TNF-α
facilitated the movement of CFTR into lipid rafts only in cells
expressing a CFTR with an intact C-terminus (not shown).
We also studied the DRM partition of Cx43 in WtCFTR
and CFTR-ΔTRL cells. On Western blot, Cx43 exhibits sev-
eral bands corresponding to the non-phosphorylated (lower
band) and phosphorylated (higher bands) forms of the proteinf Optiprep gradients as described in Materials and methods. Eight fractions [1–8]
, whereas fractions 5–8 contain the Triton-soluble material. Fraction 4 represents
g the presence of flottilin-1 (Flot-1) and caveolin-1 (Cav-1) in lipid rafts prepared
t fractions. B) Under control conditions, a small proportion of GFP-CFTR can be
n by extracting cholesterol from the cell membrane with methyl-β-cyclodextrin
ast 4 experiments.
Fig. 3. Effects of TNF-α on CFTR and Cx43 distribution in lipid rafts. A) Within 5 min, TNF-α increased the amount of CFTR in DRMs isolated from WtCFTR-
expressing cells. This phenomenon, however, was never observed in CFTR-ΔTRL-expressing cells. The M24.1 and the M3A7 antibody were used to detect WtCFTR
and CFTR-ΔTRL, respectively (B). The Triton-insoluble/soluble distribution of Cx43, another membrane channel-forming protein of the gap junction family, was not
altered by TNF-α and was similar in WtCFTR-expressing (C) and CFTR-ΔTRL-expressing (D) cells.
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two distinct pools. One pool, which was primarily the non-
phosphorylated form of Cx43, was detected in the soluble
fraction. The second pool, which exhibited non-phosphorylated
and phosphorylated forms of Cx43, was present in DRMs. This
distribution, which was similar in WtCFTR and CFTR-ΔTRL
cells, was not affected by TNF-α. These results demonstrate
that, in transfected MDCK cells, TNF-α does not induce the
movement of all membrane channel-forming proteins into
DRMs. They also indicate that TNF-α-dependent regulation of
Cx43 connectivity is independent of its recruitment to DRMs.
It is possible that detection of CFTR in lipid rafts, however,
is a consequence of forced expression of the chimeric GFP-
CFTR protein. To rule out this possibility, we performed control
experiments on Calu-3 cells, which endogenously express a
normal CFTR protein. As shown in Fig. 4A, the recruitment ofFig. 4. Detergent resistant membranes (DRMs) were prepared by ultracen-
trifugation of Optiprep gradients from Calu-3 cells. A) Western blots showing
the presence of CFTR in raft (DRMs) and non-raft fractions by the M24.1
antibody. Within 10 min, TNF-α increased the amount of CFTR in DRMs
isolated from Calu-3 cells. B) Western blots showing the presence of CFTR
(using the M24.1 antibody) in DRMs prepared from Calu-3 cells after bio-
tinylation of their cell surface.CFTR to DRMs in response to TNF-α was also observed in
these cells. In addition, lipid rafts were isolated from Calu-3
cells after biotinylation of their cell surface. Under these con-
ditions, biotinylated CFTR was recovered in detergent-resistant
membranes (Fig. 4B). These results demonstrate in an endo-
genous human glandular cell system the presence of surface
CFTR in lipid rafts.
3.4. The amount of WtCFTR in DRMs is dependent of SFK
activity
Members of the SFK family have been involved in TNF-α
signaling [20–22]. We next examined whether pharmacologi-
cal modulation of SFK activity could affect the localization of
CFTR in DRMs. To this end, the effects of pervanadate (VO4),
a tyrosine kinase activator, and of PP1, a broad inhibitor
of SFKs, were studied on the TNF-α-dependent recruitment
of CFTR to DRMs. Interestingly, we found that PP1 enhanced
the proportion of CFTR in DRMs induced by TNF-α while
VO4 reduced this proportion (Fig. 5A). In addition, PP1 alone
did recruit CFTR to DRMs to an amount representing 12.9±
4.7% of total CFTR (Fig. 5B). In contrast, experiments with
VO4 alone, cAMP-elevating agents or the CFTR inhibitor I-172
did not change the amount of CFTR in DRMs (not shown).
These results indicate that, in MDCKI cells, SFK activity
modulates the amount of CFTR in DRMs and suggest that
modulation of CFTR channel activity is independent of its
association with lipid rafts.
To search for possible SFK candidates involved in TNF-α
signaling in MDCKI cells, fractions fromWtCFTR cells exposed
to TNF-αwere immunobloted for Fyn, c-Yes or c-Src (Fig. 6A, B
and C, respectively). The location of Fyn and c-Yes, which are
present in DRMs as well as in soluble fractions, was not affected
by TNF-α (Fig. 6A and B). In contrast, the amount of c-Src
detected in DRMs was increased by TNF-α (Fig. 6C). Inte-
restingly, the presence of c-Src and CFTR in DRMs showed
Fig. 5. Pharmacological modulators of SFKs alter the proportion of CFTR in lipid rafts. A) WtCFTR-expressing cells were pre-treated with pervanadate (VO4),
a broad inhibitor of tyrosine phosphatase, or PP1, an inhibitor of tyrosine kinase, and stimulated with TNF-α. The DRM fractions shown in A are from the very same
experiment. WtCFTR cells were processed in parallel in terms of culture, treatment with the different stimuli, DRM isolation andWestern blotting. The relative amount
of CFTR in DRMs (expressed in % of total GFP-CFTR) is illustrated the bottom panel from 3 independent measurements. The M24.1 antibody was used to detect
WtCFTR. B) The amount of CFTR in DRMs (expressed in % of total CFTR) was measured inWtCFTR- and CFTR-ΔTRL-expressing cells. Under control conditions,
CFTR in DRMs represented only 5% of total CFTR (n=10). Exposure of WtCFTR cells to TNF-α (n=7) or PP1 (n=3) increased the percentage of CFTR detected in
DRMs. Methyl-β-cyclodextrin (CD) treatment reduced both the basal and stimulated amount of CFTR in DRMs (n=5). In contract to WtCFTR-expressing cells,
CFTR-ΔTRL was not present in DRMs prepared from CFTR-ΔTRL-expressing cells treated with vehicle, TNF-α or PP1 (n=6). The M24.1 and the M3A7 antibody
were used to detect WtCFTR and CFTR-ΔTRL, respectively. Asterisk indicates significance at pb0.05.
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These results suggest that c-Src is involved in TNF-α signaling in
WtCFTR MDCKI cells.
3.5. CFTR contributes to the formation of a TNFR1 signaling
complex
We found that SFKs activity modulates the proportion of
CFTR and c-Src present in DRMs in WtCFTR MDCKI cells.
Because PP1, like TNF-α, recruited CFTR to DRMs, we tested
the hypothesis that inhibition of SFKs could partially mimic
the effect of TNF-α on TNFR1 activation. TNFR1 can beFig. 6. The Triton-insoluble/soluble distribution of SFKs Fyn (A), Yes (B), and Src (C
recruitment to DRMs in response to TNF-α was only observed for c-Src. The blots ar
DRMs was measured in 14 individual experiments. The distribution of these values
amount of CFTR and c-Src in DRMs.transiently mobilized to lipid rafts where it oligomerizes and
recruits protein partners to form a receptor signaling complex in
response to TNF-α [12]. This was indeed the case in WtCFTR
cells exposed to TNF-α. As shown in Fig. 7A, TNF-α recruited
TNFR1 to DRMs within 5 min. As previously described [12],
the recruitment of TNFR1 to DRMs was transient, such that
after 20–30 min following TNF-α, TNFR1 was not longer
present in DRMs (data not shown). Interestingly, PP1 treatment
was sufficient to recruit TNFR1 to DRMs (Fig. 7A). These data
indicate that inhibition of SFKs represents a key step in the
mechanism regulating the translocation of TNFR1 and c-Src
into DRMs in WtCFTR cells. Of note, PP1 did also recruit c-Src) was examined in GFP-CFTR-expressing cells. All three SFKs were detected but
e representative of 6 experiments. D) The amount of CFTR and c-Src detected in
were plotted and a linear relationship (R2=0.91) was established between the
Fig. 7. TNFR1 and c-Src in DRMs is stimulated by inhibitors of SFKs. A) Under control conditions, TNFR1 is present in non-raft fractions. However, TNFR1 is
recruited to DRMs within 5 min in the presence of TNF-α. Translocation of TNFR1 to the Triton-insoluble fractions was also observed with PP1. Similarly, c-Src was
recruited to DRMs in response to PP1 treatment. B) Translocation of TNFR1 or c-Src to DRMs, however, was not observed in CFTR-ΔTRL-expressing cells. TNFR1
and c-Src remained in the non-raft fractions like under control conditions. Blots are representative of at least 4 experiments.
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recruitment of TNFR1 or c-Src to DRMs in CFTR-ΔTRL cells
(Fig. 7B). Finally, the observation that neither TNF-α nor PP1
recruited TNFR1 or c-Src to DRMs isolated from parental
MDCKI cells (not shown) indicates that expression of an intact
CFTR protein contributes to the formation of a TNFR1 sig-
naling complex in DRMs from MDCKI cells.Fig. 8. Inflammatory response evoked by TNF-α was investigated by NF-κB immuno
NF-κB was mostly localized in the cytoplasm under control conditions. Translocation
all WtCFTR cells. In contrast, many nuclei of CFTR-ΔTRL cells were not immunost
of the nuclear transcription factor. B) IL-8 secretion was investigated by immunoblo
markedly enhanced IL-8 secretion by WtCFTR-expressing cells, the pro-inflammator
CFTR-ΔTRL-expressing cells. Values were obtained from at least 6 experiments. A3.6. IL-8 secretion in WtCFTR and CFTR-ΔTRL MDCKI cells
To examine whether formation of a CFTR-dependent TNFR1
signaling complex in DRMS affect the biological response
of MDCKI cells, we first studied the activation of NF-κB, a
transcriptional activator of immunomodulatory genes, includ-
ing IL-8. Under control conditions, NF-κB was detected bydetection and IL-8 secretion. A) In WtCFTR and CFTR-ΔTRL-expressing cells,
of NF-κB to the nucleus was detected after 5 and 15 min of TNF-α exposure in
ained for NF-κB after TNF-α treatment, suggesting for a less efficient activation
ts in parental and transfected MDCKI cells exposed to TNF-α. Whereas TNF-α
y mediator modestly stimulated the production of IL-8 by parental (MDCKI) and
sterisk indicates significance at pb0.05.
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ΔTRL cells. In the presence of TNF-α, NF-κB was rapidly and
massively translocated to the nucleus of all WtCFTR cells, a
phenomenon that was still observed after 15 min of treatment
(Fig. 8A). This, however, was not the case in CFTR-ΔTRL
MDCKI cells whereby nuclear detection of NF-κB was he-
terogeneous with many nuclei that were not immunostained
even after 15 min of TNF-α treatment (Fig. 8A).
We next studied the secretion of IL-8 by immunoblot in
WtCFTR and CFTR-ΔTRL cells exposed to TNF-α. As shown
in Fig. 8B, TNF-αmarkedly stimulated IL-8 secretion (12.4 fold) in
WtCFTR cells. In contrast, TNF-α-induced a 2.4 fold increase of
IL-8 secretion in CFTR-ΔTRL cells. IL-8 production was also
examined in MDCKI cells expressing ΔF508CFTR. In this cell
clone, TNF-α also only modestly stimulated (1.6 fold) IL-8 secre-
tion. These results suggest that localization of the CFTR/TNFR1/
c-Src complex to lipid rafts participate in signal transduction,
affecting the inflammatory response of MDCKI cells to TNF-α.
4. Discussion
In this study, we have demonstrated in an epithelial cell
model that TNF-α recruits WtCFTR but not CFTR-ΔTRL to
DRMs in association with TNFR1 and c-Src. The recruitment
of these proteins to lipid rafts was dependent on SFK activi-
ty and required an intact C-terminus of CFTR. Moreover,
the translocation of CFTR, TNFR1 and c-Src into lipid rafts
triggered by TNF-α stimulated an intracellular signaling path-
way that regulated GJIC and IL-8 secretion in WtCFTR- but
not in CFTR-ΔTRL-expressing cells.
Several observations indicate that CFTR is present in DRMs
prepared fromWtCFTRMDCKI cells. First, CFTR was detected
in DRMs using three different antibodies (GFP, M24.1 and
M3A7). Second, CFTR was located in fractions containing
proteins that are known to be permanently associated with lipid
rafts, such as caveolin-1 and flottilin-1. Third, disruption of li-
pid rafts by cholesterol depletion abolished the detection of
CFTR in the insoluble fractions. These observations, which are
in agreement with a previous study [14], suggest that at least two
pools of CFTR exist with one small population being associated
with DRMs. Consistent with this interpretation is the detection
in lipid rafts of biotinylated cell surface CFTR in Calu-3 cells, a
human cell line endogenously expressing CFTR. The amount
of CFTR that associates with lipid rafts was temporarily increa-
sed by TNF-α in WtCFTR-expressing MDCKI cells as well as
in Calu-3 cells. This phenomenon, however, was not observed
inMDCKI cells expressing a mutant CFTR lacking its C-terminal
PDZ-binding domain. In contrast, TNF-α did not affect the
raft and non-raft partition of Cx43 in either WtCFTR or CFTR-
DTRL cells. Several members of the connexin family have
been detected in lipid rafts but it is believed that only the gap
junction precursor hemichannels are localized in DRMs [23,24].
Our data are thus consistent with the idea that TNF-α-dependent
regulation of Cx43 channel activity does not involve associa-
tion of gap junctions with lipid rafts in MDCKI cells.
It is well established that the PDZ domain containing adap-
tor molecules, such as NHERF1/EBP50 and NHERF2, asso-ciates with the C-terminal PDZ-binding motif of CFTR and
tether the channel to the actin cytoskeleton via the ERM bind-
ing domain [4]. Fluorescence recovery after photobleaching
measurements as well as fluorescence correlation spectroscopy
suggests that about 50% of CFTR is immobile at the plasma
membrane [25]. Single-particle tracking using quantum-dot
labeled CFTR showed that the channel diffusion is confined to
b200 nm in both non-polarized cells and epithelia [25,26]. It
was shown in these studies that the immobile fraction and the
diffusional mobility of CFTR were significantly increased when
CFTR binding to EBP50 was eliminated. Thus, our results are
consistent with the idea that transient PDZ interactions con-
tributes to the dynamic recruitment or clustering of CFTR to
lipid rafts in response to TNF-α. Elimination of these inter-
actions, which may alter specific localizations of CFTR to the
membrane or prevent the formation of multiprotein comple-
xes [18], may explain the defective recruitment of CFTR-ΔTRL
to DRMs in MDCKI cells.
The mechanism underlying TNF-α-dependent mobilization
of CFTR to lipid raft has not been established in this study.
Engagement of TNF-α with its cognate receptor results in the
release of the inhibitory protein silencer of death domains
(SODD), oligomerization of TNFR1 receptors and recruitment
of additional protein partners to form a receptor signaling
complex [27]. TNF-α signaling triggers a variety of biological
responses as diverse as proliferation, differentiation, inflam-
mation and apoptosis. Recent findings have suggested that
association of TNFR1 with lipid rafts determines the out-
come of TNF-α-triggered signal pathways [12]. In activated
T lymphocytes, translocation of TNFR1 into lipid raft results in
anti-apoptosis and a NF-κB-dependent pro-inflammatory
response. We found that TNF-α not only recruited CFTR
to DRMs within minutes in WtCFTR cells but also TNFR1 and
c-Src, a phenomenon that was also reproduced by inhibitors of
SFKs activity. It is therefore possible that an early step in the
recruitment of TNFR1 and protein partners into lipid rafts
involves SFK inhibition by TNF-α. These observations sug-
gest that WtCFTR confers to TNFR1 and c-Src the ability to
mobilize into lipid rafts upon TNF-α stimulation. c-Src has been
shown to interact with the cytoplasmic domain of TNFR1 [28].
Although the molecular mechanisms remain to be elucidated,
our results suggest that CFTR contributes the formation of a
TNFR1/c-Src signaling complex in DRMs. This possibility is
strengthened by the recent report of Chen and collaborators who
showed that transient anchorage of CFTR to microdomains
depends on its PDZ-binding domain and SFK inhibition [29]. In
contrast, the absence of CFTR in DRMs was associated with
abnormal TNFR1 signaling as revealed by no recruitment of
TNFR1 and c-Src to lipid rafts in cells MDCKI expressing
CFTR-ΔTRL.
There is only one study so far reporting biochemical and
functional evidence for a role of CFTR in DRMs [14]. In this
study, the non specific CD molecule was used to extract cho-
lesterol and assess lipid raft function. The differential effect of
TNF-α on CFTR recruitment to DRMs in WtCFTR and CFTR-
ΔTRL MDCKI cells that we report here therefore provides a
genetic mean to evaluate the contribution of DRM-associated
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an epithelial cell line. In this context, we evaluated TNF-α res-
ponses on GJIC and IL-8 production. In keeping with previous
reports [7,8], we observed that TNF-α decreased Cx43-mediated
GJIC in MDCK1 expressing WtCFTR. Interestingly, this regula-
tion was absent in CFTR-ΔTRL cells, suggesting that recruitment
of CFTR to DRMs is an important step for the TNFR1-dependent
regulation of Cx43 channel activity. It is well established that c-Src
tyrosine kinase activity can abolish GJIC in Cx43-expressing cells,
including normal airway epithelial cells [8,30]. It is interesting to
note that, in MDCKI cells, activation of TNFR1 signaling is
associated with the parallel recruitment of CFTR and c-Src in
DRMs. It is therefore tempting to hypothesize that complexes
containing CFTR and c-Src in DRMs may transduce signals from
membrane receptors to Cx43 channels. Whether DRM-associated
CFTR modulates the activity of c-Src in response to TNFR1
activation remains, however, to be investigated. As a second bio-
logical parameter inMDCKI cells, we have studied the secretion of
IL-8 in response to TNF-α. We observed that only WtCFTR cells
strongly responded to TNF-α in terms of IL-8 secretion whereas
MDCKI cells expressing the CFTR-ΔTRL showed modest in-
crease in their IL-8 production. This observation is consistent with
one previous study reporting that a cytokine signaling cascade is
regulated by the PDZ-binding domain of CFTR and its interaction
with EBP50 [31]. These results suggest, therefore, that WtCFTR
in lipid rafts intersects with the TNFR1 signaling cascade to regu-
late cytokine expression. Consistent with this interpretation is the
finding that nuclear translocation of NF-κB was less efficient in
MDCKI cells expressing the CFTR-ΔTRL protein.
TNFR1 signaling is central in the transmission of the innate
immune response and subsequent activation of the adaptive
immune system. The functioning of both systems is required for
optimal clearance of pathogens from the airways. Previous results
have shown that cultured human airway epithelial cells as well as
airway epithelial cells of mice expressing wild-type CFTR better
internalize Pa than cells or mice unable to express CFTR [32]. In
addition, CFTR-expressing cells showed rapid nuclear transloca-
tion of NF-κB and enhanced rate of apoptosis in response to
infection [33,34]. Our observations support therefore a scenario in
which CFTR, in association with TNFR1 and c-Src presented
within the context of lipid rafts, provides a determinant step to
coordinate inflammatory response and maintain tissue home-
ostasis. Alteration in the formation of this complex may provide
an explanation to some dysfunction of CF epithelial cells. In this
regards, we have observed that MDCKI cells expressing the
ΔF508CFTR, which does not reach the plasma membrane
and is not detected in lipid rafts [14], showed defective TNF-α-
dependent regulation of GJIC and IL-8 secretion. Thus, disrup-
tion of CFTR interactions with component of the TNFR1
complex may alter c-Src and NF-κB activities, leading to abnor-
malities that may be relevant for the CF pathogenesis.
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